Impact of the natural oligoribonucleotides in complexes with D-mannitol on tumor growth and expression of immune cell markers in a mouse melanoma В16 model
Open Access
- 30 April 2025
- journal article
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 2 (54),p. 4-11
Abstract
Cancer remains a leading cause of mortality worldwide, with chronic inflammation playing a critical role in tumour initiation and progression. Natural oligoribonucleotides in complexes with D-mannitol (ORN-D-M), derived from yeast RNA, have demonstrated anti-inflammatory and immunomodulatory effects in various disease models. Previous studies have shown their cytotoxicity against the B16 mouse melanoma cell line in vitro. This study aimed to evaluate the antitumor properties of ORN-D-M in a B16 mouse melanoma model. Materials and methods. The B16 melanoma model was established by transplantation of B16 cells into C57BL/6 mice. ORN-D-M was administered at varying doses via different routes (subcutaneous, oral, intraperitoneal), under prophylactic and therapeutic regimens, and simultaneously with transplantation of malignant cells. Tumour growth dynamics, survival, and gene expression of immune cell markers in peripheral blood (Cd3, Cd247, Cd4, Cd8, Cd68) using RT-qPCR were assessed. Results. It was shown that simultaneous administration of ORN-D-M with tumour cell transplantation dose-dependently inhibited tumour formation and improved survival. However, neither therapeutic nor prophylactic administration after tumour transplantation showed significant effects. Additionally, ORN-D-M did not affect the mRNA expression of immune cell markers during the late stage of B16 melanoma. Conclusion. ORN-D-M exhibits a dose-dependent cytotoxic effect when administered simultaneously with tumour cells but lacks efficacy in therapeutic or prophylactic regimens. Future studies should focus on optimizing targeted delivery systems to enhance drug stability and effectiveness in cancer therapyKeywords
This publication has 23 references indexed in Scilit:
- Nucleic acid-binding bis-acridine orange dyes with improved properties for bioimaging and PCR applicationsJournal of Materials Chemistry B, 2024
- Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancernpj Precision Oncology, 2023
- Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?Nature Reviews Clinical Oncology, 2021
- Toll-like Receptors and the Control of ImmunityCell, 2020
- Melanoma induced immunosuppression is mediated by hematopoietic dysregulationOncoImmunology, 2017
- Estimation of rat mammary tumor volume using caliper and ultrasonography measurementsLab Animal, 2013
- Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune responseNature Reviews Immunology, 2011
- Guidelines for the welfare and use of animals in cancer researchBritish Journal of Cancer, 2010
- Immunity, Inflammation, and CancerCell, 2010
- Diverse manifestations of tumorigenicity and immunogenicity displayed by the poorly immunogenic B16-BL6 melanoma transduced with cytokine genesCancer Immunology, Immunotherapy, 1996